Table 2.
Characteristics of Patients With Cirrhosis
| Variable | Depressed (n = 23) | Nondepressed (n = 52) | P Value |
| Age, mean (interquartile range), y | 58.0 (44–78) | 58.5 (24–76) | .75 |
| Women, n (%) | 12 (52.2) | 15 (28.8) | .07 |
| Race, n (%) | 1.00 | ||
| White | 22 (95.7) | 49 (94.2) | |
| Other | 1 (4.1) | 3 (5.8) | |
| Employed, n (%) | 13 (56.5) | 40 (76.9) | .1 |
| Total education, mean (SD), y | 13.8 (2.15) | 14.6 (2.35) | .19 |
| Diagnosis, n (%) | |||
| Alcoholic | 6 (26.1) | 17 (32.7) | .79 |
| Hepatitis C virus | 5 (21.7) | 7 (13.5) | .50 |
| Choloestatic | 3 (13.0) | 13 (25.0) | .36 |
| Nonalcoholic steatohepatitis | 2 (8.7) | 3 (5.8) | .64 |
| Other | 11 (47.8) | 21 (40.4) | .62 |
| MELD score, median (interquartile range) | 10.1 (8.0–11.0) | 10. (8.0–12.0) | .75 |
| Clinical values, median (interquartile range)a | |||
| International normalized ratio | 1.1 (1.0–1.2) | 1.1 (1.0–1.2) | .54 |
| Bilirubin (mg/dL) | 1.3 (1.0–1.7) | 1.6 (1.0–3.1) | .10 |
| Creatinine (mg/dL) | 1.0 (1.0–1.2) | 1.0 (1.0–1.2) | .67 |
| Albumin (g/dL) | 3.5 (3.1–4.3) | 3.3 (2.9–3.9) | .24 |
| Concomitant diseases, n (%)b | |||
| Diabetes mellitus | 7 (30.4) | 9 (17.3) | .23 |
| Hypertension | 5 (21.7) | 9 (17.3) | .75 |
| Other | 3 (13.0) | 13 (25.0) | .36 |
a
Patients compared using the Wilcoxon rank sum test.
b
Patients compared using the Fisher exact test.
Abbreviation: MELD = Model for End-Stage Liver Disease.